Josiah M. Slotnick

Joe represents leading investment banking firms, commercial banks and public and private issuers, with a focus on leveraged finance transactions involving both syndicated institutional loans and asset based loans and new issuance of secured and unsecured high-yield debt securities. He is recognized as a Rising Star in Banking & Finance by IFLR1000.

Joe represented the financing sources in numerous acquisitions, including the merger of Valeant Pharmaceuticals and Biovail Corporation, the acquisition of inVentiv Health by Thomas H. Lee Partners, Columbian Chemicals by Aditya Birla Group, the Gymboree Corporation by affiliates of Bain Capital Partners, HealthCare Partners by DaVita Inc., the leveraged buyout of Par Pharmaceutical by TPG Capital, L.P. and the acquisition of Medicis Pharmaceuticals Corp. by Valeant Pharmaceuticals International Inc. He also represented the financing sources in several landmark leveraged buyouts of the LBO boom, including hospital-operator HCA, Travelport, Biomet and Lyondell Chemical Company.

Joe also represents investment banks and financial advisors in connection with debt refinancings and comprehensive out-of-court debt restructurings, such as the $4.5 billion refinancing of DaVita and $5 billion exit financing for LyondellBasell's 2010 emergence from Chapter 11.

Joe has practiced in a variety of industries such as healthcare, life sciences, pharmaceuticals, financial services, technology, chemicals, telecom and gaming. He currently serves as the co-chair of Cahill’s Professional Development Committee.